New Diagnostic Tool For Ovarian Cancer (NAPSA)—According to the American Cancer Society, ovarian cancer is thefifth-leading cause of cancer death in women. Until recently, physicians often did not know if a woman’s ovarian mass was cancerous until they performed surgery to remove andtest it. Now, physicians have a new tool that assists in determining the likelihood of ovarian cancer prior to surgery: the OVA1™ Test. The OVA1 Test is the first labo- A new medical test is expected to U.S. Food and Drug Administration women with ovarian cancer. ratory blood test cleared by the (FDA) that can help a physician determine the likelihood—prior to surgery—that a woman’s ovarian mass is caused by ovarian cancer. The test was developed by Vermil- lion Inc. with support from Quest Diagnostics, the world’s leading diagnostic testing company. Cancer experts recommend patients with a cancerous ovarian tumor be under the care of a physician specializing in gynecological cancers. However, only one in three women with an ovarian mass is referred to these specialists. The OVAI1 Test is expected to improve treatment outcomes for women with ovarian cancer by improve treatment outcomesfor cians make decisions about a patient’s care,” said Frederick R. Ueland, M.D., associate professor gynecologic oncology at the University of Kentucky’s Markey Cancer Center and principal investigator of the prospective, multicenter OVA1clinical trial. The OVAI1 Test is available through Quest Diagnostics’ network of laboratories and patient service centers throughout the United States. Quest Diagnostics is now the only diagnostic testing company to offer FDA-cleared “When combined with other ovarian cancer tests intended for use before and after surgery to remove a mass. In addition to the OVA1 Test, Quest Diagnostics also offers HE4 Monitoring and CA125 Tests, which the FDA has cleared ous before surgery and help physi- rence of certain ovarian cancers. Learn more at www.Quest Diagnostics.com. helping physicians direct patients to the most appropriate surgeon for care. clinical information, the OVA1 Test can help assess the likelihood that an ovarian tumoris cancer- as aids in monitoring for recur- Tips for Catching Ovarian Cancer Common Symptoms Bloating Pelvic/AbdominalPain Ditficulty Eating/Feeling Full Quickly Urinary Urgency/Frequency D
